Both the facilities are spread over 5000 square feet of lab space, broadening the range of tests offered by CORE to 1500+ tests
CORE Diagnostics announced the launch of two new labs in Delhi and Bengaluru, respectively, as part of their aggressive plans to expand their footprint in India and shift beyond their B2B offerings. The Delhi Lab in Green Park is fully operational and has been accepting samples across Delhi NCR, and the second diagnostic lab in Richmond Circle, Bengaluru has just started operations.
The facilities will provide a wide range of tests starting from health packages to launching reproductive testing to high-end molecular testing. CORE Diagnostics continues to offer home collection facilities at various locations, ensuring test results are delivered promptly. The quick turnaround time of reporting from being located closer to the customer will vastly expand the base of customers that can be serviced. Within a year, CORE Diagnostics will have the capability to pick up samples from over 300 cities across India and with deeper global expansion planned across Asia, Middle East and Africa.
In addition to these owned and operated labs, CORE is also expanding through partnerships. The company has recently partnered with GJ Diagnostics Lab in Ludhiana to expand its presence across Punjab and with the Institute of Liver and Biliary Sciences, New Delhi on Next Generation Sequencing (NGS) testing.
Dinesh Chauhan, CEO, CORE Diagnostics, said, “We, at CORE, have constantly endeavoured to ensure affordable and accessible high-end diagnostics to all. These two new labs are the first steps in our commitment to expand our presence and meet the increasing demand for high-quality diagnostics. With our investment in automation and our sustained efforts to bring in advanced testing in India, we are building customer touchpoints enabling a high-quality experience for our customers. We are delighted to be executing on our vision of making quality diagnostics accessible to more people through our partnerships and lab expansion plans. We look to provide timely and the highest quality of diagnostic services to over 300 Indian cities and to expand our presence in countries across Asia, Middle East and Africa.”
The Bengaluru lab is the first major investment in South India and will also serve as a digital pathology hub. All samples collected in Bengaluru will be scanned, and examined by the pathologists in CORE’s Gurgaon lab and referred to our global panel of organ specialists if necessary.
